Monographie - Ceftaroline fosamil

Ostatnia aktualizacja :
19/11/2024

Ceftaroline fosamil

Struktura chemiczna

Nazwa handlowa

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Zinforo

Argentyna, Belgia, Chile, Francja , Hiszpania, Islandia, Malezja, Meksyk, Niemcy, Norwegia, Rumunia, Szwajcaria, Wielka Brytania

Bibliografia : Ceftaroline fosamil

	typ	publikacja
3249	Czasopismo	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3520	Laboratorium	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3549	Laboratorium	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3643	Laboratorium	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3674	Laboratorium	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3812	Czasopismo	Bhattacharya S, Parekh S, Dedhiya M. In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers. Int J Pharm Compound 2015 ; 19, 5 : 432-436.
3827	plakat	Ghazi I.M, Hamada Y, Nicolau D.P. Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions. ASHP Midyear 2015
3828	plakat	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	plakat	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
4055	Czasopismo	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4059	Czasopismo	Madfai F, Zaidi S, Ming L, Wanandy T, Patel R. Physical and chemical stability of ceftaroline in an elastomeric infusion device. EJHP 2017 ; 25, e2
4145	Czasopismo	Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P. Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4434	Czasopismo	Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration. Clin Ther 2019 ; 41, 10: 2162-2170.
4528	Czasopismo	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4801	Czasopismo	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:

Mentions Légales